Effect of Extraesophageal Reflux on Inferior Nasal Turbinates Hypertrophy
1 other identifier
interventional
160
2 countries
3
Brief Summary
The study examines the severity of extraesophageal reflux using oropharyngeal pH monitoring in patients with varying degrees of lower turbinates hypertrophy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2020
CompletedFirst Posted
Study publicly available on registry
October 9, 2020
CompletedStudy Start
First participant enrolled
October 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2021
CompletedDecember 7, 2022
December 1, 2022
12 months
October 2, 2020
December 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Severity of extraesophageal reflux using oropharyngeal pH monitoring
The primary outcome measure of the study is to examine the severity of extraesophageal reflux using oropharyngeal pH monitoring in patients with varying degrees of lower turbinates hypertrophy, assessed on the RYAN score.
24 hours
Study Arms (4)
1st degree of hypertrophy according to Camacho
EXPERIMENTALPatients with 1st degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.
2nd degree of hypertrophy according to Camacho
EXPERIMENTALPatients with 2nd degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.
3rd degree of hypertrophy according to Camacho
EXPERIMENTALPatients with 3rd degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.
4th degree of hypertrophy according to Camacho
EXPERIMENTALPatients with 4th degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.
Interventions
Patients with the 1st degree of hypertrophy according to Camacho, 2nd degree of hypertrophy according to Camacho, 3rd degree of hypertrophy according to Camacho, 4th degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.
Eligibility Criteria
You may qualify if:
- age 18-80 years
- patients indicated for oropharyngeal pH-metry (Restech) with suspected extraesophageal reflux
- patients with 2nd - 4th degree hypertrophy of the lower turbinates (according to Camacho Classification)
You may not qualify if:
- patients with chronic rhinosinusitis with polyps
- patients who have had an acute upper respiratory tract infection in the last 8 weeks
- patients after previous surgery in the nasal cavity and nasopharynx
- patients after radiotherapy in the head and neck area
- non tolerance of pH catheter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Ostravalead
- University Hospital Bratislavacollaborator
- Fortmedica Praguecollaborator
Study Sites (3)
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, 70852, Czechia
Fortmedica Prague
Prague, 14300, Czechia
Comenius University, University Hospital Bratislava
Bratislava, 85107, Slovakia
Related Publications (7)
Camacho M, Zaghi S, Certal V, Abdullatif J, Means C, Acevedo J, Liu S, Brietzke SE, Kushida CA, Capasso R. Inferior turbinate classification system, grades 1 to 4: development and validation study. Laryngoscope. 2015 Feb;125(2):296-302. doi: 10.1002/lary.24923. Epub 2014 Sep 12.
PMID: 25215619BACKGROUNDFarmer SE, Eccles R. Chronic inferior turbinate enlargement and the implications for surgical intervention. Rhinology. 2006 Dec;44(4):234-8.
PMID: 17216738BACKGROUNDCamacho M, Zaghi S, Certal V, Abdullatif J, Modi R, Sridhara S, Tolisano AM, Chang ET, Cable BB, Capasso R. Predictors of Nasal Obstruction: Quantification and Assessment Using Multiple Grading Scales. Plast Surg Int. 2016;2016:6945297. doi: 10.1155/2016/6945297. Epub 2016 May 16.
PMID: 27293885BACKGROUNDAyazi S, Lipham JC, Hagen JA, Tang AL, Zehetner J, Leers JM, Oezcelik A, Abate E, Banki F, DeMeester SR, DeMeester TR. A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J Gastrointest Surg. 2009 Aug;13(8):1422-9. doi: 10.1007/s11605-009-0915-6. Epub 2009 May 7.
PMID: 19421822BACKGROUNDChheda NN, Seybt MW, Schade RR, Postma GN. Normal values for pharyngeal pH monitoring. Ann Otol Rhinol Laryngol. 2009 Mar;118(3):166-71. doi: 10.1177/000348940911800302.
PMID: 19374146BACKGROUNDWiener GJ, Tsukashima R, Kelly C, Wolf E, Schmeltzer M, Bankert C, Fisk L, Vaezi M. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice. 2009 Jul;23(4):498-504. doi: 10.1016/j.jvoice.2007.12.005. Epub 2008 May 12.
PMID: 18468849BACKGROUNDZelenik K, Matousek P, Formanek M, Urban O, Kominek P. Patients with chronic rhinosinusitis and simultaneous bronchial asthma suffer from significant extraesophageal reflux. Int Forum Allergy Rhinol. 2015 Oct;5(10):944-9. doi: 10.1002/alr.21560. Epub 2015 Jun 5.
PMID: 26046448BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karol ZelenÃk, Ass.Prof.,MD,PhD
University Hospital Ostrava
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking is being used in this study
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2020
First Posted
October 9, 2020
Study Start
October 15, 2020
Primary Completion
September 30, 2021
Study Completion
October 30, 2021
Last Updated
December 7, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data may be made available to other researchers upon request.